NOVO-B.CO vs. BRK-B
NOVO-B.CO (Novo Nordisk A/S) and BRK-B (Berkshire Hathaway Inc.) are both stocks. NOVO-B.CO operates in Biotechnology (Healthcare), while BRK-B operates in Insurance - Diversified (Financial Services). Over the past 10 years, NOVO-B.CO returned 17.36%/yr vs 12.93%/yr for BRK-B. At a 0.14 correlation, their price movements are largely independent.
Performance
NOVO-B.CO vs. BRK-B - Performance Comparison
Loading charts...
Different Trading Currencies
NOVO-B.CO is traded in DKK, while BRK-B is traded in USD. To make them comparable, the BRK-B values have been converted to DKK using the latest available exchange rates.
Returns By Period
In the year-to-date period, NOVO-B.CO achieves a -8.64% return, which is significantly lower than BRK-B's -1.10% return. Over the past 10 years, NOVO-B.CO has outperformed BRK-B with an annualized return of 17.36%, while BRK-B has yielded a comparatively lower 12.93% annualized return.
NOVO-B.CO
- 1D
- 1.66%
- 1M
- -3.99%
- YTD
- -8.64%
- 6M
- -7.47%
- 1Y
- -41.76%
- 3Y*
- 4.58%
- 5Y*
- 20.64%
- 10Y*
- 17.36%
BRK-B
- 1D
- 0.82%
- 1M
- 1.98%
- YTD
- -1.10%
- 6M
- -0.53%
- 1Y
- 0.44%
- 3Y*
- 10.82%
- 5Y*
- 12.41%
- 10Y*
- 12.93%
NOVO-B.CO vs. BRK-B - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
NOVO-B.CO Novo Nordisk A/S | -8.64% | -46.40% | -9.59% | 205.34% | 31.49% | 79.08% | 15.29% | 36.17% | -6.15% | 39.57% |
BRK-B Berkshire Hathaway Inc. | -1.10% | -2.10% | 35.54% | 12.28% | 9.76% | 38.40% | -6.44% | 13.52% | 8.10% | 6.78% |
Correlation
The correlation between NOVO-B.CO and BRK-B is -0.06, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.06 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.05 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.06 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.09 |
Correlation (All Time) Calculated using the full available price history since Sep 7, 2007 | 0.14 |
The correlation between NOVO-B.CO and BRK-B shifts across timeframes, from -0.06 (1 year) to 0.14 (all time), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NOVO-B.CO vs. BRK-B — Risk / Return Rank
NOVO-B.CO
BRK-B
NOVO-B.CO vs. BRK-B - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Novo Nordisk A/S (NOVO-B.CO) and Berkshire Hathaway Inc. (BRK-B). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NOVO-B.CO | BRK-B | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.79 | ||
| Sortino ratioReturn per unit of downside risk | -1.03 | ||
| Omega ratioGain probability vs. loss probability | 0.87 | 1.01 | -0.14 |
| Calmar ratioReturn relative to maximum drawdown | -0.78 | 0.01 | -0.79 |
| Martin ratioReturn relative to average drawdown | -1.15 | 0.03 | -1.18 |
Loading charts...
Drawdowns
NOVO-B.CO vs. BRK-B - Drawdown Comparison
The maximum NOVO-B.CO drawdown since its inception was -76.75%, which is greater than BRK-B's maximum drawdown of -46.03%. Use the drawdown chart below to compare losses from any high point for NOVO-B.CO and BRK-B.
Loading charts...
Drawdown Indicators
| NOVO-B.CO | BRK-B | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -76.75% | -46.03% | -30.72% |
Max Drawdown (1Y)Largest decline over 1 year | -54.63% | -11.03% | -43.60% |
Max Drawdown (3Y)Largest decline over 3 years | -76.75% | -20.43% | -56.32% |
Max Drawdown (5Y)Largest decline over 5 years | -76.75% | -22.32% | -54.43% |
Max Drawdown (10Y)Largest decline over 10 years | -76.75% | -28.73% | -48.02% |
Current DrawdownCurrent decline from peak | -70.15% | -14.55% | -55.60% |
Average DrawdownAverage peak-to-trough decline | -11.29% | -9.77% | -1.52% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 37.11% | 5.01% | +32.10% |
Volatility
NOVO-B.CO vs. BRK-B - Volatility Comparison
Novo Nordisk A/S (NOVO-B.CO) has a higher volatility of 11.47% compared to Berkshire Hathaway Inc. (BRK-B) at 4.24%. This indicates that NOVO-B.CO's price experiences larger fluctuations and is considered to be riskier than BRK-B based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NOVO-B.CO | BRK-B | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.47% | 4.24% | +7.23% |
Volatility (6M)Calculated over the trailing 6-month period | 39.57% | 11.47% | +28.10% |
Volatility (1Y)Calculated over the trailing 1-year period | 54.40% | 15.13% | +39.27% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 58.56% | 17.38% | +41.18% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 45.08% | 20.10% | +24.98% |
Dividends
NOVO-B.CO vs. BRK-B - Dividend Comparison
NOVO-B.CO's dividend yield for the trailing twelve months is around 4.07%, while BRK-B has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BRK-B Berkshire Hathaway Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NOVO-B.CO Novo Nordisk A/S | 4.07% | 3.58% | 1.59% | 1.01% | 2.38% | 2.54% | 4.03% | 4.22% | 5.27% | 4.54% | 7.38% | 2.50% |
Financials
NOVO-B.CO vs. BRK-B - Financials Comparison
This section allows you to compare key financial metrics between Novo Nordisk A/S and Berkshire Hathaway Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
NOVO-B.CO and BRK-B have a correlation of -0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for NOVO-B.CO and BRK-B
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer